Explore evidence

0.1 %One patient (0.1%; 95% CI, 0.0%-0.2%) had acute hepatitis B among 762 HIV-1-positive adults from Gabon surveyed between 2010 and 2013.

Gabonhépatite B · VIH/sidaobserved 2010-2013published 2016PloS onePubMeddocument of 7 observations

75 %Viral load suppression was achieved by 75% of people living with HIV receiving antiretroviral therapy in Bunia.

GabonVIH/sidapublished 2026Diseases (Basel, Switzerland)PubMeddocument of 5 observations

26 %The case fatality rate among hospitalised PLHIV with tuberculosis was 26.0% (n = 24).

Gabontuberculose · VIH/sidaobserved 2021-2022published 2025Southern African journal of infectious diseaseseurope_pmcdocument of 11 observationsDOI 10.4102/sajid.v40i1.695

34.7 %Visual impairment was bilateral in 34.7% of the 75 people living with HIV who had visual impairment.

GabonVIH/sida · visual impairmentpublished 2023Le Mali medicalPubMeddocument of 6 observations

57.9 %57.9% of people living with HIV/AIDS had developed opportunistic infections.

Gabonopportunistic infections · VIH/sidapublished 2024Viruseseurope_pmcdocument of 5 observations

0.43 infectionsThe mean number of vector-borne infections was 0.43 (standard deviation 0.63) in HIV-positive pregnant women.

Gabonvector-borne infections · VIH/sidapublished 2023Infectious diseases of povertyPubMeddocument of 7 observations

12.9 %Cryptococcal neuromeningitis accounted for 12.9% of diagnoses among HIV-infected patients with meningeal or encephalitic syndromes in Libreville, Gabon.

Gaboncryptococcal neuromeningitis · VIH/sidaobserved 2006–2010published 2016African health sciencesPubMeddocument of 11 observations

3.5 %Hepatitis E seroprevalence was 3.5% among 762 adults infected with HIV-1 in Gabon.

Gabonhepatitis E · VIH/sidapublished 2017Medecine et sante tropicalesPubMeddocument of 8 observations

1.3 ratioThe mean dN/dS ratio was 1.3 ± 0.7 in the (I, VF) subgroup.

GabonVIH/sidapublished 2020Journal of clinical medicine researchPubMeddocument of 4 observations

9.83 monthsThe median survival among HIV-positive cervical cancer patients was 9.83 months, compared to 20.10 months among HIV-negative patients.

Gaboncancer du col de l'utérus · VIH/sidaobserved January 2010 to April 2017published 2021Obstetrics and gynecology internationalPubMeddocument of 4 observations

3.7 %HPV-45 prevalence among HIV-infected women in Ouagadougou was 3.7%.

GabonVIH/sidaobserved 2009–2010published 2011Acta tropicaeurope_pmcdocument of 8 observations

8.8 %HCV seroprevalence was 8.8% among 762 adults infected with HIV-1 in Gabon.

Gabonhépatite C · VIH/sidapublished 2017Medecine et sante tropicalesPubMeddocument of 8 observations

739 individualsOf the 1634 individuals placed on antiretroviral treatment (ART) in a rural district in Malawi between April 2003 and December 2004, 739 received no community support.

GabonVIH/sidaobserved between April 2003 and December 2004published 2007Transactions of the Royal Society of Tropical Medicine and Hygieneeurope_pmcdocument of 7 observations

9.3 %Seventy-one (9.3%) patients tested positive for HBsAg among 762 HIV-1-positive adults from Gabon surveyed between 2010 and 2013.

Gabonhépatite B · VIH/sidaobserved 2010-2013published 2016PloS onePubMeddocument of 7 observations

0.14 %HIV-2 seroprevalence was 0.14% among 12,287 pregnant women screened during the study period.

GabonVIH/sidaobserved 2003-2013published 2014Pakistan journal of biological sciences : PJBSeurope_pmcdocument of 8 observations

35.7 %Between 2012 and 2015, 35.7% of people living with HIV entered care in less than 28 days at two outpatient treatment centers in Libreville.

GabonVIH/sidaobserved 2012-2015published 2025Medecine tropicale et sante internationaleeurope_pmcdocument of 4 observations

24.6 %The prevalence of urine Cryptococcus antigen (CrAg) was 24.6% among 142 HIV-infected patients tested in Libreville, Gabon, from April to October 2021.

Gabonméningite cryptococcique · VIH/sidaobserved April to October 2021published 2024Tropical medicine and infectious diseaseeurope_pmcdocument of 2 observations

0.43 hazard_ratioEarly starting anti-retroviral therapy was associated with a decreased risk of loss to follow-up (adjusted hazard ratio 0.43, 95% confidence interval 0.24–0.76).

GabonVIH/sidaobserved 2010–2012published 2015PloS onePubMeddocument of 5 observations

9.5 %No aetiology was determined in 9.5% of cases among HIV-infected patients with meningeal or encephalitic syndromes in Libreville, Gabon.

GabonVIH/sidaobserved 2006–2010published 2016African health sciencesPubMeddocument of 11 observations

59.4 %Viral load suppression (VL < 1000 copies/mL) was 59.4% among women receiving antiretroviral therapy in semi-rural Franceville, Gabon.

GabonVIH/sidapublished 2021The Journal of antimicrobial chemotherapyPubMeddocument of 7 observations

2.7 odds_ratioAmong HIV-positive cervical cancer patients, tumor was diagnosed at advanced stages (stages III–IV) with an odds ratio of 2.70 (95% CI: 1.43–5.08).

Gaboncancer du col de l'utérus · VIH/sidaobserved January 2010 to April 2017published 2021Obstetrics and gynecology internationalPubMeddocument of 4 observations

16.7 %Prostration occurred in 16.7% of PLHIV with malaria.

Gabonpaludisme · VIH/sidaobserved 2021 to 2022published 2026PloS onePubMeddocument of 11 observations

60.6 %Asymptomatic malaria was more frequent among HIV-negative participants (60.6%) than among PLHIV (25.0%).

Gabonpaludisme · VIH/sidaobserved 2021 to 2022published 2026PloS onePubMeddocument of 11 observations

2.8 %HIV strains in the studied population showed reduced susceptibility to antiretroviral drugs in 2.8% of cases.

GabonVIH/sidapublished 2012BMC Infectious DiseasesOpenAlexdocument of 14 observationsDOI 10.1186/1471-2334-12-64

48.3 %In 48.3% of the cases, HIV infection was diagnosed at a late stage (WHO 3 or 4) among people living with HIV seen at two outpatient treatment centers in Libreville between 2012 and 2020.

GabonVIH/sidaobserved 2012-2020published 2025Medecine tropicale et sante internationaleeurope_pmcdocument of 4 observations